Characterization of ocular adverse events associated with crizotinib: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase

To evaluate the risk of ocular adverse events (AEs) associated with crizotinib using real-world data from FAERS and VigiBase, and to characterize signal patterns through disproportionality and time-to-onset (TTO) analyses. Reports from FAERS and VigiBase (2011–2025) were analyzed. Disproportionality...

Cur síos iomlán

Sonraí bibleagrafaíochta

Príomhchruthaitheoirí:	Shuai Dong, Zhi-chao Jiang, Li Gao, Rong Zhang, Yan Liu
Formáid:	Artigo
Teanga:	Inglês
Foilsithe / Cruthaithe:	Frontiers Media S.A. 2025-12-01
Sraith:	Frontiers in Oncology
Ábhair:	crizotinib ocular adverse events FAERS VigiBase disproportionality analysis
Rochtain ar líne:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1735200/full
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!